Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Amongst sufferers with relapsed/refractory follicular lymphoma, fixed-duration Epkinly (epcoritamab) plus Rituxan (rituximab) and Revlimid (lenalidomide; R2) was related to important enhancements in...
Amongst match sufferers with acute myeloid leukemia, the mix of azacitidine plus Venclexta (venetoclax) was related to a considerably improved event-free survival...
Amongst sufferers with acute myeloid leukemia, Black race has been discovered to be an impartial prognostic issue for decrease survival outcomes, no...
Amongst sufferers experiencing persistent graft-versus-host illness (cGVHD), the transition of remedy with Niktimvo (axatilimab) to a dose of 0.6 milligrams per kilogram...
